Cardinal Health Files 8-K for Regulation FD Disclosure

TL;DR

Cardinal Health filed an 8-K for a Reg FD disclosure on Jan 14, 2025. Details TBD.

AI Summary

On January 14, 2025, Cardinal Health, Inc. filed a Form 8-K to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.

Why It Matters

This filing indicates Cardinal Health is making a public disclosure under Regulation FD, ensuring all investors receive material information simultaneously. It suggests a need for transparency on a specific, unstated matter.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure without immediate negative or positive financial implications.

Key Players & Entities

• Cardinal Health, Inc. (company) — Registrant
• January 14, 2025 (date) — Date of earliest event reported
• Ohio (location) — State of incorporation

FAQ

Key Financial Figures

• $7.75 — end of its previously provided range of $7.75 to $7.90, primarily driven by continued
• $7 — s previously provided range of $7.75 to $7.90, primarily driven by continued stren

Filing Documents

• cah-20250114.htm (8-K) — 28KB
• 0000721371-25-000003.txt ( ) — 150KB
• cah-20250114.xsd (EX-101.SCH) — 2KB
• cah-20250114_lab.xml (EX-101.LAB) — 21KB
• cah-20250114_pre.xml (EX-101.PRE) — 12KB
• cah-20250114_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure Cardinal Health, Inc. (the "Company") is providing an update to its previously announced expectations for non-GAAP diluted earnings per share ("non-GAAP EPS") for fiscal year 2025. The Company now expects fiscal year 2025 non-GAAP EPS to be toward the high end of its previously provided range of $7.75 to $7.90, primarily driven by continued strength within the Pharmaceutical and Specialty Solutions segment. The Company will present at the JP Morgan 43 rd Annual Healthcare Conference today, January 14, 2025, at 12:00 P.M. Eastern Time. The presentation will include comments related to this update, among other things. The Company also expects to provide further details on its expectations for fiscal year 2025 results on its second quarter earnings call on January 30, 2025. To view a live webcast of this these events, please visit our Investor Relations page at ir.cardinalhealth.com. The company does not provide forward-looking guidance on a GAAP basis as certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. Cautions Concerning Forward-Looking Statements This Form 8-K contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include the risk that we may fail to achieve our strategic objectives, including the continued execution of the GMPD Improvement Pl

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: January 14, 2025 By: /s/ AARON E. ALT Aaron E. Alt Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR